Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Knapp

Showing results (671-680 of 689) with videos related to

Pageof 69
Sort By:
Veterinary Journal (London, England : 1997)|November 24, 2023
Association between cigarette smoke exposure and urinary bladder cancer in Scottish terriers in a cohort studyD W Knapp, D Dhawan, A Ruple, et al.
Veterinary and Comparative Oncology|April 22, 2009
Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladderP A Boria, N W Glickman, B R Schmidt, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 3, 2011
Cancer prevention interdisciplinary education program at Purdue University: overview and preliminary resultsDorothy Teegarden, Ji-Yeon Lee, Omolola Adedokun, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|March 19, 2015
Canine urothelial carcinoma: genomically aberrant and comparatively relevantS G Shapiro, S Raghunath, C Williams, et al.
British Journal of Haematology|June 19, 2001
Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patientsM C Béné, M Bernier, R O Casasnovas, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Blood|July 1, 1997
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinaseI Rappold, B L Ziegler, I Köhler, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog BreedBreann C Sommer, Deepika Dhawan, Audrey Ruple, et al.
Journal of Veterinary Internal Medicine|March 1, 1996
Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993)P J Bergman, E G MacEwen, I D Kurzman, et al.
Journal of Veterinary Internal Medicine|December 5, 2012
Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladderD W Knapp, C J Henry, W R Widmer, et al.
Pageof 69

Showing results (671-680 of 689) with videos related to

Sort By:
Pageof 69
Veterinary Journal (London, England : 1997)|November 24, 2023
Association between cigarette smoke exposure and urinary bladder cancer in Scottish terriers in a cohort studyD W Knapp, D Dhawan, A Ruple, et al.
Veterinary and Comparative Oncology|April 22, 2009
Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladderP A Boria, N W Glickman, B R Schmidt, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 3, 2011
Cancer prevention interdisciplinary education program at Purdue University: overview and preliminary resultsDorothy Teegarden, Ji-Yeon Lee, Omolola Adedokun, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|March 19, 2015
Canine urothelial carcinoma: genomically aberrant and comparatively relevantS G Shapiro, S Raghunath, C Williams, et al.
British Journal of Haematology|June 19, 2001
Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patientsM C Béné, M Bernier, R O Casasnovas, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Blood|July 1, 1997
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinaseI Rappold, B L Ziegler, I Köhler, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog BreedBreann C Sommer, Deepika Dhawan, Audrey Ruple, et al.
Journal of Veterinary Internal Medicine|March 1, 1996
Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993)P J Bergman, E G MacEwen, I D Kurzman, et al.
Journal of Veterinary Internal Medicine|December 5, 2012
Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladderD W Knapp, C J Henry, W R Widmer, et al.
Pageof 69